Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.

J Infect Dis · 2022 · PMC9417129 · PMID 32584386

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

borderline significantP = .08so close (0.05 < p ≤ 0.1)

For patients with cirrhosis, the difference between age groups (75–84 vs 60–74 years) in the development of HCC was borderline significant ( P = .08).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.